Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+70.5%
5Y CAGR+24.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+70.5%/yr
vs -8.2%/yr prior
5Y CAGR
+24.5%/yr
Recent acceleration
Acceleration
+78.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $145.64M | +75.2% |
| 2024 | $83.11M | +153.1% |
| 2023 | $32.84M | +11.8% |
| 2022 | $29.38M | +133.1% |
| 2021 | $12.61M | -74.1% |
| 2020 | $48.64M | -15.2% |
| 2019 | $57.37M | +38.8% |
| 2018 | $41.34M | +48.2% |
| 2017 | $27.90M | +382.5% |
| 2016 | $5.78M | - |